High-dose topotecan, thiotepa and melphalan (TTM regimen) with autologous stem cell support for adult metastatic soft tissue sarcoma

被引：0
|
作者：
Naparstek, E [1 ]
Harishanu, Y [1 ]
Rom, E [1 ]
Gipstein, L [1 ]
Aviv, F [1 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S258 / S259
页数：2
相关论文
共 50 条
  • [1] High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma
    Donato, ML
    Aleman, A
    Champlin, RE
    Weber, D
    Alexanian, R
    Ippoliti, CM
    De Lima, M
    Anagnostopoulos, A
    Giralt, S
    LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 755 - 759
  • [2] Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma
    S M A Kazmi
    R M Saliba
    M Donato
    M Wang
    C Hosing
    S Qureshi
    P Anderlini
    U Popat
    R E Champlin
    S A Giralt
    M H Qazilbash
    Bone Marrow Transplantation, 2011, 46 : 510 - 515
  • [3] Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma
    Kazmi, S. M. A.
    Saliba, R. M.
    Donato, M.
    Wang, M.
    Hosing, C.
    Qureshi, S.
    Anderlini, P.
    Popat, U.
    Champlin, R. E.
    Giralt, S. A.
    Qazilbash, M. H.
    BONE MARROW TRANSPLANTATION, 2011, 46 (04) : 510 - 515
  • [4] High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer
    Donato, ML
    Gershenson, DM
    Wharton, JT
    Ippoliti, CM
    Aleman, AS
    Bodurka-Bevers, D
    Bevers, MW
    Burke, TW
    Levenback, CF
    Wolf, JK
    Freedman, RS
    Bast, RC
    Gajewski, JL
    Champlin, RE
    GYNECOLOGIC ONCOLOGY, 2001, 82 (03) : 420 - 426
  • [5] High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma
    Carli, M
    Colombatti, R
    Oberlin, O
    Stevens, M
    Masiero, L
    Frascella, E
    Koscielniak, E
    Treuner, J
    Pinkerton, CR
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2796 - 2803
  • [6] Recommend upfront consolidation with high-dose melphalan and autologous stem cell support
    Shah, Gunjan L.
    Giralt, Sergio A.
    SEMINARS IN ONCOLOGY, 2016, 43 (06) : 707 - 708
  • [7] High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma
    Atra, A
    Whelan, JS
    Calvagna, V
    Shankar, AG
    Ashley, S
    Shepherd, V
    Souhami, RL
    Pinkerton, CR
    BONE MARROW TRANSPLANTATION, 1997, 20 (10) : 843 - 846
  • [8] High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcoma
    A Atra
    JS Whelan
    V Calvagna
    AG Shankar
    S Ashley
    V Shepherd
    RL Souhami
    CR Pinkerton
    Bone Marrow Transplantation, 1997, 20 : 843 - 846
  • [9] High-dose chemotherapy containing topotecan, thiotepa and carboplatin with autologous stem cell rescue for high-risk medulloblastorna
    Muramatsu, H
    Matsumoto, K
    Kato, K
    Inao, S
    BONE MARROW TRANSPLANTATION, 2005, 35 : S390 - S390
  • [10] Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma
    Chang, Julie E.
    Juckett, Mark B.
    Callander, Natalie S.
    Kahl, Brad S.
    Gangnon, Ronald E.
    Mitchell, Teri L.
    Longo, Walter L.
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (03): : 153 - 158
12345